Malignancies in HIV/AIDS
Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients
The link between CD8+ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate
Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
DNA methylation profiling can classify HIV-associated lymphomas
Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection
CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission
Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy
HIV-1 seroreversion in HIV-1-infected children
Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2
High attrition before and after ART initiation among youth (15–24 years of age) enrolled in HIV care
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4+ cell counts
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings
What is the significance of posttreatment control of HIV infection vis-à-vis functional cure?
Generic antiretroviral drugs in developing countries
Decreasing cardiovascular risk in HIV infection between 2005 and 2011
Abacavir-induced liver toxicity in an HIV-infected patient
Effect of HIV-2 infection on HIV-1 disease progression and mortality
Effect of HIV-2 infection on HIV-1 disease progression and mortality
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers